Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

In this last episode, our panel discusses this patient population and the challenges around keeping them in the continuum of care.

A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.

The therapy was previously granted accelerated approval for the thyroid cancer indications in adults and pediatric patients aged 12 years and older.

Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.

Approximately 1 in 5 youths who identify as a sexual gender minority will undergo a gender identity change in their adolescence; however, such changes do not appear to impact their mental health.

The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.